COMPOSITION PHARMACEUTIQUE DESTINÉE À ÊTRE UTILISÉE POUR LA MODIFICATION DU CUIR CHEVELU OU DE LA PEAU, LA CICATRISATION D'UNE PLAIE OU LA MODIFICATION DES CHEVEUX
The present invention provides a pharmaceutical composition for use in modifying scalp or skin, promoting wound healing, or modifying hair, comprising a secretion from adipose stem cells as an active ingredient, wherein 0.3 to 0.6 µg of the secretion in terms of protein abundance per site in scalp or skin is administered.